Navigation Links
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
Date:5/30/2008

riatr Pharmacother 2006;4(3):244-50.

(10) Barkun et al. The cost-effectiveness of high-dose oral proton pump

inhibition after endoscopy in the acute treatment of peptic ulcer

bleeding. Aliment Pharmacol Ther 2004; 20: 195-202.

(11) Barkun et al. High-dose intravenous proton pump inhibition following

endoscopic therapy in the acute management of patients with bleeding

peptic ulcers in the USA and Canada: a cost-effectiveness analysis

Aliment Pharmacol Ther 2004; 19: 591-600.


'/>"/>
SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
2. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
3. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
4. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
5. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
8. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
9. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
10. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
11. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... Chief Financial Officer, will be presenting at the Barclays Capital Global Healthcare Conference on Wednesday, March 24 at 8:30 am Eastern Time .  The conference ... ... ... ...
(Date:3/17/2010)... (Nasdaq: KNDL ), a leading, global full-service clinical research organization, ... will address the World Pharma Trials Asia 2010 conference being ... Centre in Singapore . Dr. Horsburgh,s presentation, "Accelerating Oncology Clinical ... at 2 p.m. local time.  World Pharma Trials ...
(Date:3/17/2010)... The latest advancement in facial contouring, the AccuLift™ procedure, was just featured on CBS, The Early Show .  New York physician Dr. Jon Turk introduced the ... ... ... ...
Breaking Medicine Technology:DURECT to Present at the Barclays Capital Global Healthcare Conference 2DURECT to Present at the Barclays Capital Global Healthcare Conference 3Kendle Executive to Share Insights at World Pharma Trials Asia 2010 2Kendle Executive to Share Insights at World Pharma Trials Asia 2010 3'The AccuLift Phenomenon' Kicks off on CBS' The Early Show 2'The AccuLift Phenomenon' Kicks off on CBS' The Early Show 3CIGGX the 100 25 Natural Smokers Aid That Reduces the Desire to Smoke Selects TransMedia Group as Their PR Firm 49571 1CIGGX the 100 25 Natural Smokers Aid That Reduces the Desire to Smoke Selects TransMedia Group as Their PR Firm 49571 2WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U S Operations 12717 1WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U S Operations 12717 2Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 1Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 2Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 3Platelet Rich Plasma Therapy 28PRP 29 Accelerates Healing of Joint Injuries Osteoarthritis Pain 49564 4
... 3b Studies with Durezol Dosed Prior to Surgery, ... Inc., a,privately held ophthalmic-focused biopharmaceutical company, announced,today that ... Durezol, which was approved by the U.S. Food ... ophthalmic corticosteroid,indicated for the treatment of inflammation and ...
... Conference Call Scheduled for 9:00 AM ET ... Dendreon Corporation (Nasdaq:,DNDN) announced today that it ... Phase 3, randomized, double-blind, placebo-controlled IMPACT,(IMmunotherapy for ... trial designed to assess the safety and ...
Other Medicine Technology:Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4
(Date:3/21/2010)... and founder of the conservative grassroots public policy organization Eagle Forum, made the following remarks after the public announcement that formerly pro-life Democrat Bart Stupak ... ... , ... ... ...
(Date:3/21/2010)... Barack Obama is trying to lure anti-abortion Democrats to vote yes for ... abortion funding with an Executive Order. But Executive Orders cannot change the law. ... Sawyer , 33 US 579 (1952). , ... ... ...
(Date:3/21/2010)... humans, scientists used RNA to stop production of ... News) -- For the first time in humans, ... enter tumor cells and block the production of ... , "They,re basically putting an instruction booklet ... protein expressed for now," explained Gregory Adams, co-leader ...
(Date:3/18/2010)... ... way people perceive negative events – it can actually take a toll on health, according ... ... Low self-esteem doesn’t just impact the way people perceive negative events – it can actually ...
(Date:3/18/2010)... ... ... ... Kids in Minnesota will take center stage in the fight against tobacco on March 24 as they join thousands of young people nationwide for the 15th ...
Breaking Medicine News(10 mins):Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 2Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 3Health News:Betsy McCaughey Says Anti-Abortion Democrats Should not be Hoodwinked by President's Promise of Executive Order 'Fix' 2Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 2Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 3Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 2Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 3Health News:Minnesota Kids 'Kick Butts' on March 24 2Health News:Minnesota Kids 'Kick Butts' on March 24 3Health News:Minnesota Kids 'Kick Butts' on March 24 4Health News:Minnesota Kids 'Kick Butts' on March 24 5
... with prostate cancer who receive a common medication aimed to ... of recurrence after surgery may be at increased risk for ... androgen deprivation therapy (ADT) after prostate cancer run a higher ... Men who are older, smoke, or suffer from alcoholism are ...
... an individual is born in may play a role in ... the nervous system disorder multiple sclerosis.// ,Results showed ... disease while people born in November are at lowest risk. ... to those with November birthdays. Conversely people born in November ...
... Latest research has shown that treatment with the oral ... an often fatal disease, pulmonary arterial hypertension ( PAH) ... immunodeficiency virus infection. HIV infection is believed to cause ... small pulmonary arteries to become obstructed. This chronic obstruction ...
... of the drug rolipram in mice shows promise for possible ... according to a new study. ,Alzheimer's disease is the ... symptoms being memory loss, speech deterioration, and behavioral changes. The ... of beta-amyloid, which is toxic to the brain. ,Researchers ...
... a lumpectomy may be safe for breast cancer patients ... study. Standard treatment for women with breast cancer usually ... undergoing surgery , however for most women the length ... leading them to choose mastectomy instead of breast conservation. ...
... were treated for depression responded better if they had ... An increasing amount of research is looking at the ... have not been understood. Researchers conducted a study to ... treatment of depression. ,The study included 115 patients ...
Other Medicine News:
... encoded by the ob gene and is produced ... a key role in the regulation of body ... Leptin functions as a lipostat and is produced ... Increased serum leptin levels signal the brain to ...
... also known as Anti-Mullerian Inhibiting Substance (AMH), ... 72 kDa monomers linked by disulfide bridges ... factor-? (TGF-?) superfamily which includes TGF-? and ... All members of this superfamily are dimeric ...
... (EPO) is the primary known naturally-occurring stimulant ... molecular weight of human EPO is 18.2 ... of EPO has an estimated molecular mass ... to have a unique structure, the EPO ...
... in the parafollicular C-cells of the thyroid ... The major action of calcitonin is to ... activity, resulting in decreased mobilization of calcium ... evident in conditions associated with high levels ...
Medicine Products: